AVNS Strangle Strategy
AVNS (Avanos Medical, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
AVNS (Avanos Medical, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $1.16B, a beta of 1.59 versus the broader market, a 52-week range of 9.303-24.91, average daily share volume of 1.3M, a public-listing history dating back to 2014, approximately 2K full-time employees. These structural characteristics shape how AVNS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.59 indicates AVNS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on AVNS?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current AVNS snapshot
As of May 15, 2026, spot at $24.73, ATM IV 39.00%, IV rank 12.18%, expected move 11.18%. The strangle on AVNS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on AVNS specifically: AVNS IV at 39.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a AVNS strangle, with a market-implied 1-standard-deviation move of approximately 11.18% (roughly $2.77 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVNS expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVNS should anchor to the underlying notional of $24.73 per share and to the trader's directional view on AVNS stock.
AVNS strangle setup
The AVNS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVNS near $24.73, the first option leg uses a $25.97 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVNS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVNS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $25.97 | N/A |
| Buy 1 | Put | $23.49 | N/A |
AVNS strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
AVNS strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on AVNS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on AVNS
Strangles on AVNS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AVNS chain.
AVNS thesis for this strangle
The market-implied 1-standard-deviation range for AVNS extends from approximately $21.96 on the downside to $27.50 on the upside. A AVNS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current AVNS IV rank near 12.18% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AVNS at 39.00%. As a Healthcare name, AVNS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVNS-specific events.
AVNS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVNS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVNS alongside the broader basket even when AVNS-specific fundamentals are unchanged. Always rebuild the position from current AVNS chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on AVNS?
- A strangle on AVNS is the strangle strategy applied to AVNS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With AVNS stock trading near $24.73, the strikes shown on this page are snapped to the nearest listed AVNS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AVNS strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the AVNS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 39.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AVNS strangle?
- The breakeven for the AVNS strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AVNS market-implied 1-standard-deviation expected move is approximately 11.18%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on AVNS?
- Strangles on AVNS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AVNS chain.
- How does current AVNS implied volatility affect this strangle?
- AVNS ATM IV is at 39.00% with IV rank near 12.18%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.